Mylan Inc
-
Mylan launches generic version of Remdesivir in India for COVID-19 patients
Business | Jul 20, 2020, 02:46 PM ISTPharma major Mylan on Monday said it has commercially launched the generic version of Remdesivir drug under the brand name 'Desrem' in India for treatment of coronavirus patients.
-
USFDA accepts proposed biosimilar application by Mylan, Biocon for review
Business | Mar 09, 2020, 12:51 PM ISTThe US Food and Drug Administration (USFDA) has accepted biologics license application by Mylan and Biocon for proposed biosimilar to Bevacizumab for review, according to a regulatory filing.
-
Mylan's Rs 5,168-cr proposal to acquire Agila cleared
Aug 28, 2013, 10:04 AM ISTNew Delhi: The Foreign Investment Promotion Board (FIPB) has cleared US-based pharmaceutical firm Mylan Inc's Rs 5,168 crore proposal to acquire Indian generic drugs company Agila Specialties.The proposal will now have to be approved by
Advertisement
Advertisement